Cornerstone Advisors (Washington)’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-216
Closed -$11K 1313
2019
Q2
$11K Buy
216
+96
+80% +$4.84K ﹤0.01% 762
2019
Q1
$6K Buy
120
+36
+43% +$1.62K ﹤0.01% 807
2018
Q4
$3K Hold
84
﹤0.01% 846
2018
Q3
$4K Buy
84
+24
+40% +$1.06K ﹤0.01% 802
2018
Q2
$2K Hold
60
﹤0.01% 870
2018
Q1
$2K Buy
60
+40
+200% +$1.41K ﹤0.01% 852
2017
Q4
$1K Hold
20
﹤0.01% 883
2017
Q3
$1K Hold
20
﹤0.01% 889
2017
Q2
$1K Hold
20
﹤0.01% 886
2017
Q1
$1K Hold
20
﹤0.01% 886
2016
Q4
$1K Hold
20
﹤0.01% 915
2016
Q3
$1K Hold
20
﹤0.01% 889
2016
Q2
$1K Buy
+20
New +$514 ﹤0.01% 838
2015
Q2
Sell
-20
Closed -$1K 785
2015
Q1
$1K Buy
+20
New +$475 ﹤0.01% 743

Other funds holding TECH

Cornerstone Advisors (Washington)'s TECH Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of Bio-Techne (TECH) in Q3 2019, closing a stake of 216 shares — an estimated $11K sold.

Cornerstone Advisors (Washington) first reported a position in TECH in Q1 2015 and held it in 14 quarters. The position peaked at $11K in Q2 2019. 341 funds tracked by Wall St. Rank hold TECH as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining Bio-Techne position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 216 Bio-Techne shares in Q3 2019, an estimated $11K.
  • Cornerstone Advisors (Washington) first reported a position in Bio-Techne in Q1 2015 and held it in 14 quarters.
  • Cornerstone Advisors (Washington)'s Bio-Techne position peaked at $11K in Q2 2019.
  • 341 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.